Phase 2 clinical trial data of argenx’s (ARGX) product Efgartigimod (ARGX-113) in adult patients with primary immune …

Gilead Sciences (GILD) has news that we felt good about it for a company that saved …

In the Week in Review posted yesterday on our website that is experiencing several attempts on …

Gilead Sciences’ (GILD) and Galapagos’ (GLPG) product filgotinib – a highly selective JAK1 inhibitor has met …

The Week in Review #28 The approval of revolutionary products created by biotech firms with solid …

A complete response letter (CRL) sent by The Division of Metabolism and Endocrinology Products of the …

Portola (PTLA) has two important approved breakthrough products and an investigational product having promising results on …

Celyad (CYAD) is an immuno-oncology firm, which created CAR T CELL treatments for cancers, including  solid …

Vertex Pharmaceuticals (VRTX) announced that the Pharmaceutical Benefits Advisory Committee’s (PBAC) in Australia recommendation the listing …

Aerie Pharmaceuticals (AERI) announced results from a double-masked, randomized, placebo-controlled study designed to evaluate the effect …